Bariatric Surgery and COVID-19: a Change of Perspective in a New Phase of the Pandemic.
Bariatric surgery
COVID-19
Obesity
RYGB
SARS-CoV-2
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
22
08
2023
accepted:
20
10
2023
revised:
20
10
2023
medline:
30
11
2023
pubmed:
29
10
2023
entrez:
28
10
2023
Statut:
ppublish
Résumé
The protective role of bariatric surgery (BS) against COVID-19 has been reported by several studies, showing, in the first pandemic waves, better outcome of the infection in patients that had undergone BS. With the virus progressive endemicity, BS benefits on COVID-19 clinical course could appear less evident, while COVID-19 effects on BS outcomes must be investigated. In this national multicentric cross-sectional study, we compared COVID-19 incidence and clinical course between a cohort of patients that had undergone BS (OP) and a cohort of candidates to BS (WS); moreover, we analyzed BS outcomes based on SARS-CoV-2 positivity/negativity. From June to December 2021, 522 patients from five Italian referral centers were administered an 87-item telephonic questionnaire completing the analysis of electronic medical records. Demographics, COVID-19 "tested" incidence, suggestive symptoms and clinical outcome parameters of OP and WS were compared. BS outcomes parameters were compared between OP that developed the disease or not. COVID-19 incidence was the same in OP and WS, while symptoms and clinical course seemed milder in OP, with no data individually reaching statistical significance. OP who developed SARS-CoV-2 infection had higher excess weight loss than negative OP (66.8% ± 22.1 vs. 57.7% ± 22.8, p = 0.029). Positive OP had had gastric-bypass (RYGB/OAGB) more frequently than negative ones (38.4% vs. 18.2%, p = 0.025). With the disease becoming endemic, BS protective role against COVID-19 seems clinically less relevant. BS outcomes can be affected by COVID-19, thus imposing careful follow-up for positive patients, especially if undergoing gastric-bypass.
Identifiants
pubmed: 37897638
doi: 10.1007/s11695-023-06923-6
pii: 10.1007/s11695-023-06923-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4049-4057Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ. 2020;368.
Hussain A, Mahawar K, El-Hasani S. The impact of COVID-19 pandemic on obesity and bariatric surgery. Obes Surg. 2020.
World Health Organization. World Health Organization (WHO) COVID-19 dashboard [Internet]. World Health Organization (WHO). 2023 Available from: https://covid19.who.int/ .
Msemburi W, Karlinsky A, Knutson V, et al. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613:130–7.
doi: 10.1038/s41586-022-05522-2
pubmed: 36517599
Sarkar A, Omar S, Alshareef A, et al. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review. Hum Vaccin Immunother.;NLM (Medline). 2023:2212568.
European Centre for Disease Prevention and Control (ECDC). Guidelines for the implementation of non-pharmaceutical interventions against COVID-19 key messages general considerations on NPI to control COVID-19. Stockholm; 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidelines-non-pharmaceutical-interventions-september-2020.pdf .
Flaxman S, Mishra S, Gandy A, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584:257–61.
doi: 10.1038/s41586-020-2405-7
pubmed: 32512579
Cohen JF, Korevaar DA, Matczak S, et al. COVID-19–related fatalities and intensive-care-unit admissions by age groups in Europe: a meta-analysis. Front Med (Lausanne). 2021;7.
Rahman S, Montero MTV, Rowe K, et al. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol. 2021:14.
Sattar N, Valabhji J, Fm NS. Obesity as a risk factor for severe COVID-19: summary of the best evidence and implications for health care. Curr Obes Rep. 2021;10:282–9. https://doi.org/10.1007/s13679-021-00448-8 .
doi: 10.1007/s13679-021-00448-8
pubmed: 34374955
pmcid: 8353061
Huang Y, Lu Y, Huang YM, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabol. 2020;113.
Gao M, Piernas C, Astbury NM, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021:9.
Courcoulas AP, King WC, Belle SH, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA Surg. 2018:153.
Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg. 2016:151.
Riccò M, Marchesi F, Tartamella F, et al. The impact of bariatric surgery on health outcomes, wellbeing and employment rates: analysis from a prospective cohort study. Ann Ig. 2017;29.
Dixon AE, Beiko T. Bariatric Surgery to Prevent COPD Exacerbations? Chest. 2018;153:586–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0012369217327204 .
doi: 10.1016/j.chest.2017.08.1174
pubmed: 29519297
Alsumali A, Al-Hawag A, Bairdain S, et al. The impact of bariatric surgery on pulmonary function: a meta-analysis. Surg Obes Relat Diseas. 2018;14.
Sarkhosh K, Switzer NJ, El-Hadi M, et al. The impact of bariatric surgery on obstructive sleep apnea: a systematic review. Obes Surg. 2013.
Purdy AC, Hohmann SF, Nguyen NT. Outcomes of obese patients hospitalized with COVID-19: the impact of prior bariatric surgery. Surg Obes Relat Diseas. 2022;18.
Uccelli M, Cesana GC, De Carli SM, et al. COVID-19 and obesity: is bariatric surgery protective? Retrospective analysis on 2145 patients undergone bariatric-metabolic surgery from high volume center in Italy (Lombardy). Obes Surg. 2021;31.
Marchesi F, Valente M, Riccò M, et al. Effects of bariatric surgery on COVID-19: a multicentric study from a high incidence Area. Obes Surg. 2021; Available from: http://link.springer.com/10.1007/s11695-020-05193-w .
Caranci N, Di Girolamo C, Bartolini L, et al. General and COVID-19-related mortality by pre-existing chronic conditions and care setting during 2020 in Emilia-Romagna region, Italy. Int J Environ Res Public Health. 2021;18.
Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020.
Welbourn R, Pournaras DJ, Dixon J, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the second IFSO global registry report 2013–2015. Obes Surg. 2018;28:313–22.
doi: 10.1007/s11695-017-2845-9
pubmed: 28822052
The EUROPEAN parliament and the Council of the European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of such Data, and Repealing Directive 95/46/EC (General Data Protection Regulation). Off J Eur Union. 2016;L1197/2.
Zanettini C, Omar M, Dinalankara W, et al. Influenza vaccination and covid-19 mortality in the USA: an ecological study. Vaccines (Basel). 2021:9.
Noale M, Trevisan C, Maggi S, et al. The association between influenza and pneumococcal vaccinations and sars-cov-2 infection: data from the epicovid19 web-based survey. Vaccines (Basel). 2020;8:1–12.
Sawadogo W, Tsegaye M, Gizaw A, et al. Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis: BMJ Nutr Prev Health; 2022.
Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID-19–related hospitalization, intensive care unit admission, Invasive mechanical ventilation, and death—United States, March–December 2020. MMWR Surveill Summ. 2021:70.
Cai Z, Zhong J, Jiang Y, et al. Bariatric surgery and COVID-19 outcomes: a systematic review and meta-analysis. Surg Obes Relat Diseas. 2023.
Jones RL, Nzekwu MMU. The effects of body mass index on lung volumes. Chest. 2006;130.
Navarra G, Komaei I, Currò G, et al. Bariatric surgery and the COVID-19 pandemic: SICOB recommendations on how to perform surgery during the outbreak and when to resume the activities in phase 2 of lockdown. Updates Surg. 2020:72.
Almario CV, Chey WD, Spiegel BMR. Increased risk of COVID-19 among users of proton pump inhibitors. Am J Gastroenterol. 2020;115.
Donati Zeppa S, Agostini D, Piccoli G, et al. Gut microbiota status in COVID-19: an unrecognized player? Front Cell Infect Microbiol. 2020.
Ejtahed HS, Angoorani P, Hasani-Ranjbar S, et al. Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: a systematic review. Microb Pathog. 2018;116.
Moradpour G, Amini M, Moeinvaziri N, et al. Bariatric surgery and COVID-19: what we have learned from the pandemic in Iran: a retrospective observational cohort study. Obes Surg. 2022;32.
Frish N, Israel A, Ashkenazi S, et al. The association of weight reduction and other variables after bariatric surgery with the likelihood of SARS-CoV-2 infection. J Clin Med. 2023:12.